Nonetheless, germline alterations in DNA damage repair genes such as BRCA1/2, PALB2, and ATM, as well as MMR deficiency, are clinically relevant in PDAC due to their therapeutic implications (20). Here, PALB2 is linked to mismatch repair cancer syndrome 1.